Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medivolve Inc MEDVF

Medivolve, Inc. is a Canada-based healthcare technology company. The Company has two business units: Medivolve Pharmacy Division (MPD) and Collection Sites Diagnostics (CSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine, and psychiatry to patients in Southern California. CSD’s software platform, Electronic Health Records app (EHR), is focused on supporting clinical staff, is a series of assets and functionalities that enhance the customer experience and provide an end-to-end lab solution. The Company, through its subsidiaries, Medivolve Pharmacy Inc., and Kedy Ying Jao D.O., a medical corporation, operate a distributed network of two retail patient-care locations in California, United States. The Company has served hundreds of thousands of patients across the United States and facilitated more than 1,533,000 clinical tests.


OTCPK:MEDVF - Post by User

Comment by RapsAloton Nov 11, 2020 9:43am
135 Views
Post# 31876623

RE:Rapsalot sir

RE:Rapsalot sirThey are under the radar. I said that about a month ago actually.  I have a background in finance and a low SP never surprises me when revenue isn't flowing. Yes I get 17 cubes are bringing in revenue but they are keeping that quite. Once the cubes are in place, the investors will come. It appears they are waiting on a big bang. Perhaps one large NR stating 299 cubes now bringing in revenue around Dec 1st. Until then I personally don't sweat SP. We will see. Marketing will come. Today's NR was focused on the holidays and so was the CBS interview done on the 9th. I searched for it but could not find. It was pretaped so maybe coming out before American Thanksgiving or closer to Christmas. 

Some companies like organic SP growth. Makes for quality investors and less turbulent SP. Bigger picture. 

optex1972 wrote:

So first off thanks for what seems to be incredible insight. 


curious as you seem to be in kmow why is it this company is so incredibly under the radar? How is it management has not spent the dough to go onto BNN to tell this story? I'm baffled honestly as to what the goal here is wouldn't you be wanting to circle in large investment?

what do you think the real holdup or strategy is here?

thanks for your time!



<< Previous
Bullboard Posts
Next >>

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse